Dj%2525252525252525252520citral

# Citral *Note: Citral (3,7-dimethyl-2,6-octadienal) is an acyclic monoterpene aldehyde found in essential oils (e.g., lemongrass). It is primarily used as a flavoring agent/fragrance and lacks standardized clinical therapeutic dosing or FDA-approved indications for systemic disease management.* ## Overview Citral is a natural plant component investigated primarily for anti-inflammatory, antimicrobial, and sedative properties. It is not an established pharmaceutical agent; clinical data is limited to experimental or traditional settings. ## Primary Indications Not officially indicated for any medical condition. Investigational uses include: * Antimicrobial and antifungal adjuvant. * Anti-inflammatory therapeutic in preclinical models. * Sedative/anxiolytic evaluation. ## Adult Dosing There is no standard clinical dose. In flavoring/food use, it is Generally Recognized as Safe (GRAS) by the FDA. Therapeutic trials in literature vary wildly and are not supported by standardized guidelines. **Do not use for curative intent.** ## Pediatric Dosing No established pediatric safety or efficacy data. **Avoid use in children.** ## Dose Adjustments No guidelines exist. Given the risk of contact dermatitis and potential enzyme induction, avoid use in patients with hepatic or renal impairment. ## Contraindications * Hypersensitivity to citral or lemongrass oils. * Known contact dermatitis or skin sensitivity. ## Adverse Effects * **Dermatologic:** High frequency of allergic contact dermatitis. Use in topical preparations is strictly regulated by IFRA (International Fragrance Association) to prevent sensitization. * **Sensory:** Mucosal irritation if ingested in concentrated forms. * **Systemic:** High-dose ingestion in animal models has shown potential endocrine interference and hepatotoxicity (at supraphysiological levels). ## Key Drug Interactions * **CYP450 Enzymes:** Potential for induction or inhibition of various CYP isoforms; efficacy of concurrent narrow-therapeutic-index medications may be compromised. * **Photosensitization:** May increase sensitivity to UV light in certain topical applications. ## Monitoring * Monitor skin for localized redness, pruritus, or vesicular eruptions. * In experimental settings, monitor liver function tests (LFTs) if chronic exposure occurs. ## Clinical Pearls * **Sensitization:** Citral is a well-documented skin sensitizer. Pure citral should never be applied directly to the skin without proper dilution in a carrier. * **Quality Control:** Commercial essential oils vary significantly in purity and concentration. Contamination with heavy metals or synthetic adulterants is common. * **Regulatory Status:** It is a chemical component, not a drug. Do not substitute for standard pharmacotherapy. *** **Educational Disclaimer:** This information is for educational purposes only. Citral is not an FDA-approved medication. Clinical practice varies by institution and jurisdiction. Always verify prescribing information and local protocols via current, peer-reviewed clinical databases (e.g., Lexicomp, Micromedex) before making clinical decisions.